Summary:
Click image to enlargeHealthy and High Risk Patients 6-17 years old are currently being recruited for a Covid-19 Vaccine Trial in Phase III. The purpose of the trial is for safety and effectiveness of an investigational vaccine for Covid-19. Effectiveness if proven will show the immune system respond against the virus of SARS-CoV-2.
Qualified Participants Must:
• 6-17 years of age
•
Have not had Covid-19 already, that they are aware of
•
Willing and able to participate
•
Will be screened by site for further qualifications
Qualified Participants May Receive:
- Up to $1300 for time and travel
- 24 months of study participation and medical oversite for trial